Heart and Lungs in COPD. Close friends in real life - separate in daily medical practice?

Heart and Lungs in COPD. Close friends in real life - separate in daily medical practice?

Chronic obstructive pulmonary disease (COPD) is associated with a 2-3 times higher rate of cardiovascular disorders (CVD) which is independent of other risk factors. A low FEV1 is a specific predictor of mortality as a result of cardiac causes, even stronger than increased cholesterol: for each 10%...

Full description

Bibliographic Details
Main Authors:	M. Lusuardi, G. Garuti, M. Massobrio, L. Spagnolatti, S. Bendinelli
Format:	Article
Language:	English
Published:	PAGEPress Publications 2016-01-01
Series:	Monaldi Archives for Chest Disease
Subjects:	Chronic obstructive pulmonary disease Cardiovascular disorders Spirometry Bronchodilators Beta-blockers
Online Access:	https://www.monaldi-archives.org/index.php/macd/article/view/406

Similar Items

Ischemic Heart Disease during Acute Exacerbations of COPD
by: Rosa Malo de Molina, et al.
Published: (2018-09-01)

Spirometric Indices after Bronchodilator Test in Obstructive Lung Disease
by: Amir Houshang Mehrparvar, et al.
Published: (2010-07-01)

Spirometric Indices after Bronchodilator Test in Obstructive Lung Disease
by: Amir Houshang Mehrparvar, et al.
Published: (2010-08-01)

Bronchodilator reversibility in patients with COPD revisited: short-term reproducibility
by: Pascoe S, et al.
Published: (2016-08-01)

Risk factors for cardiovascular disease in patients with COPD: mild-to-moderate COPD versus severe-to-very severe COPD
by: Laura Miranda de Oliveira Caram, et al.

Inhaler Devices for Delivery of LABA/LAMA Fixed-Dose Combinations in Patients with COPD
by: Anthony D’Urzo, et al.
Published: (2019-03-01)

Reducing cholinergic constriction: the major reversible mechanism in COPD
by: V. Brusasco
Published: (2006-12-01)

Virus-Induced Asthma/Wheeze in Preschool Children: Longitudinal Assessment of Airflow Limitation Using Impulse Oscillometry
by: Konstantinou N George, et al.
Published: (2019-09-01)

Prevention of exacerbations of COPD with pharmacotherapy
by: M. Miravitlles
Published: (2010-06-01)

Broncodilatação na DPOC: muito além do VEF1-efeito do salbutamol nas propriedades resistivas e reativas do sistema respiratório Bronchodilation in COPD: beyond FEV1-the effect of albuterol on resistive and reactive properties of the respiratory system
by: Gerusa Marítimo da Costa, et al.
Published: (2009-04-01)

Risk stratification for COPD diagnosis through an active search strategy in primary care
by: Marcos PJ, et al.
Published: (2016-03-01)

Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study
by: Damkjær M, et al.
Published: (2021-08-01)

Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study
by: Danilo Cortozi Berton, et al.

Impacting patient-centred outcomes in COPD: breathlessness and exercise tolerance
by: D. E. O'Donnell
Published: (2006-12-01)

A study of correlation between body mass index and GOLD staging of chronic obstructive pulmonary disease patients
by: Mrinmoy Mitra, et al.
Published: (2013-01-01)

Impact of beta‐blocker use on the long‐term outcomes of heart failure patients with chronic obstructive pulmonary disease
by: Yoshiaki Kubota, et al.
Published: (2021-10-01)

Clinical experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2019-12-01)

Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease
by: Oda N, et al.
Published: (2017-04-01)

Exercise and dyspnoea in COPD
by: P. M. A. Calverley
Published: (2006-12-01)

Global initiative gold and national recommendations on the management of patients with chronic obstructive pulmonary disease (COPD): the place of double bronchodilation
by: A. A. Vizel, et al.
Published: (2019-12-01)

Risk factors for respiratory hospitalizations in a population of patients with a clinical diagnosis of COPD
by: Veljanovski J, et al.
Published: (2018-03-01)

The Impact of Bronchodilator Therapy on Systolic Heart Failure with Concomitant Mild to Moderate COPD
by: Mahoto Kato, et al.
Published: (2017-12-01)

Validation of a COPD screening questionnaire and establishment of diagnostic cut-points in a Japanese general population: The Hisayama study
by: Go Tsukuya, et al.
Published: (2015-01-01)

Tiotropium as essential maintenance therapy in COPD
by: M. Decramer
Published: (2006-12-01)

Influence of heart failure on resting lung volumes in patients with COPD
by: Aline Soares de Souza, et al.

Bronchodilator treatment of stable COPD: long-acting anticholinergics
by: W. Vincken
Published: (2005-09-01)

Usefulness of spirometry in hospitalized patients with Chronic Obstructive Pulmonary Disease (COPD) exacerbated
by: Hernández-Ruiz, Alfredo, et al.
Published: (2020-10-01)

Beta-blocker under-use in COPD patients
by: Lim KP, et al.
Published: (2017-10-01)

Lung hyperinflation in COPD: the impact of pharmacotherapy
by: D. E. O'Donnell, et al.
Published: (2006-12-01)

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study
by: Wedzicha JA, et al.
Published: (2017-01-01)

Impact of Comorbidities and Commonly Used Drugs on Mortality in COPD – Real-World Data from a Primary Care Setting
by: Ellingsen J, et al.
Published: (2020-02-01)

Experience of using double bronchodilation therapy in patients with COPD
by: I. V. Demko, et al.
Published: (2021-01-01)

Change in inhaled corticosteroid treatment and COPD exacerbations: an analysis of real-world data from the KOLD/KOCOSS cohorts
by: Se Hee Lee, et al.
Published: (2019-03-01)

Clinical Characteristics Of Patients With Asthma COPD Overlap (ACO) In Australian Primary Care
by: Izbicki G, et al.
Published: (2019-12-01)

Effects of Age on 1-Second Forced Expiratory Volume Response to Bronchodilation
by: Ching-Lung Liu, et al.
Published: (2009-09-01)

Elevated cardiovascular risk among adults with obstructive and restrictive airway functioning in the United States: a cross-sectional study of the National Health and Nutrition Examination Survey from 2007–2010
by: Ford Earl S, et al.
Published: (2012-12-01)

Do spirometry for patients with cardiovascular diseases?
by: B M Nazarov, et al.
Published: (2013-06-01)

Long-acting muscarinic antagonists vs. long-acting β 2 agonists in COPD exacerbations: a systematic review and meta-analysis
by: Israel Silva Maia, et al.

Efficacy and safety of twice-daily glycopyrrolate in patients with stable, symptomatic COPD with moderate-to-severe airflow limitation: the GEM1 study
by: LaForce C, et al.
Published: (2016-06-01)

Bronchodilator efficacy of 18 µg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial
by: Yildiz P, et al.
Published: (2016-11-01)